Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes

Brain Imaging and Behavior

Volumn 9, Issue 4, 2015, Pages 651-662

  Moulton, Calum D ^a   Costafreda, Sergi G ^b   Horton, Paul ^a   Ismail, Khalida ^a   Fu, Cynthia H Y ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

Atrophy; Dementia; Depression; Diabetes; Inflammation; Meta analysis

Indexed keywords

AGE; ANTERIOR CINGULATE; BASAL GANGLION; BRAIN ATROPHY; BRAIN SIZE; DEPRESSION; FRONTAL LOBE; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCIPITAL LOBE; ORBITAL CORTEX; PARIETAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; REVIEW; SUPERIOR TEMPORAL GYRUS; SYSTEMATIC REVIEW; THALAMUS; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; IMAGE PROCESSING; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY;

ATROPHY; BRAIN; DIABETES MELLITUS, TYPE 2; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; ORGAN SIZE;

EID: 84948588301     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-014-9348-2     Document Type: Review

References (83)

1. Ali, S., Stone, M. A., Peters, J. L., Davies, M. J., & Khunti, K. (2006). The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetic Medicine, 23, 1165–1173.
2. Alosco, M., Brickman, A. M., Spitznagel, M. B., Griffith, E. Y., Narkhede, A., Raz, N., et al. (2013). The adverse impact of type 2 diabetes on brain volume in heart failure. Journal of Clinical and Experimental Neuropsychology, 35, 309–318.
3. Anan, F., Masaki, T., Shimomura, T., Fujiki, M., Umeno, Y., Eshima, N., et al. (2010). Abdominal visceral fat accumulation is associated with hippocampus volume in non-dementia patients with type 2 diabetes mellitus. NeuroImage, 49, 57–62.
4. Anan, F., Masaki, T., Shimomura, T., Fujiki, M., Umeno, Y., Eshima, N., et al. (2011). High-sensitivity C-reactive protein is associated with hippocampus volume in nondementia patients with type 2 diabetes mellitus. Metabolism, Clinical and Experimental, 60, 460–66.
5. Ashburner, J., & Friston, K. J. (2000). Voxel-based morphometry–the methods. NeuroImage, 11(6 Pt 1), 805–21.
6. Aye, T., Reiss, A. L., Kesler, S., Hoang, S., Drobny, J., Park, Y., et al. (2011). The feasibility of detecting neuropsychological and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care, 34, 1458–1462.
7. Balakrishnan, S., Mathew, J., & Paulose, C. S. (2010). Cholinergic and glutamergic receptor functional regulation in long-term, low dose somatotropin and insulin treatment to ageing rats: rejuvenation of brain function. Mollecular and Cellular Endocrinology, 314, 23–30.
8. Ballmaier, M., Toga, A. W., Blanton, R. E., Sowell, E. R., Lavretsky, H., et al. (2004). Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. American Journal of Psychiatry, 161, 99–108.
9. Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006). Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurology, 5, 64–74.
10. Bondy, C., Bach, M. A., & Lee, W.-H. (1992). Mapping of brain insulin and insulin-like growth factor receptor gene expression by in situ hybridization. Neuroprotocols, 1, 240–249.
11. Brands, A. M., Biessels, G. J., de Haan, E. H., Kappelle, L. J., & Kessels, R. P. (2005). The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care, 28, 726–735.
12. Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Annual Review of Medicine, 46, 223–234.
13. Bruehl, H., Wolf, O. T., & Convit, A. (2009). A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology, 34, 815–821.
14. Brundel, M., van den Heuvel, M., de Bresser, J., Kappelle, L. J., & Biessels, G. J. (2010). Cerebral cortical thickness in patients with type 2 diabetes. Journal of the Neurological Sciences, 299, 126–130.
15. Chen, Z., Li, L., Sun, J., & Ma, L. (2012). Mapping the brain in type II diabetes: voxel-based morphometry using DARTEL. European Journal of Radiology, 81, 1870–1876.
16. Cole, J., Costafreda, S. G., McGuffin, P., & Fu, C. H. Y. (2011). Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. Journal of Affective Disorders, 134, 483–487.
17. Colman, I., Jones, P. B., Kuh, D., Weeks, M., Naicker, K., Richards, M., & Croudace, T. J. (2014). Early development, stress and depression across the life course: pathways to depression in a national British birth cohort. Psychological Medicine, 44(13), 2845–54.
18. Costafreda, S. G. (2012). Parametric coordinate-based meta-analysis: valid effect size meta-analysis of studies with differing statistical thresholds. Journal of Neuroscience Methods, 210, 291–300.
19. de Bresser, J., Tiehuis, A. M., van den Berg, E., Reijmer, Y. D., Jongen, C., Kappelle, L. J., et al. (2010). Progression of cerebral atrophy and white matter hypersensitivites in patients with type 2 diabetes. Diabetes Care, 33, 1309–1314.
20. de Jong, L. W., van der Hiele, K., Veer, I. M., Houwing, J. J., Westendorp, R. G., Bollen, E. L., et al. (2008). Strongly reduced volumes of putamen and thalamus in Alzheimer’s disease: an MRI study. Brain, 131, 3277–3285.
21. den Heijer, T., Vermeer, S. E., van Dijk, E. J., Prins, N. D., Koudstaal, P. J., Hofman, A., et al. (2003). Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia, 46, 1604–1610.
22. Deng, Y., Li, B., Liu, Y., Iqbal, K., Grundke-Iqbal, I., & Gong, C. X. (2009). Dysregulation of insulin signalling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer’s disease. American Journal of Pathology, 175, 2089–2098.
23. DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.
24. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson, A. M., Musen, G., Ryan, C. M., Silvers, N., Cleary, P., et al. (2007). Long-term effect of diabetes and its treatment on cognitive function. New England Journal of Medicine, 356, 1842–1852.
25. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., et al. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67, 446–457.
26. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., & Kolachana, B. S. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 2003(112), 257–69.
27. Elder, G. A., De Gasperi, R., & Gama Sosa, M. A. (2006). Research update: neurogenesis in adult brain and neuropsychiatric disorders. Mount Sinai Journal of Medicine, 73, 931–40.
28. Espeland, M. A., Bryan, R. N., Goveas, J. S., Robinson, J. G., Siddiqui, M. S., Liu, S., et al. (2013). Influence of type 2 diabetes on brain volumes and changes in brain volumes. Diabetes Care, 36, 90–97.
29. Frodl, T., Carballedo, A., Hughes, M. M., Saleh, K., Fagan, A., Skokauskas, N., et al. (2012). Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Translational Psychiatry, 2, e88.
30. Fu, C. H. Y., Steiner, H., & Costafreda, S. G. (2013). Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiology of Disease, 52, 75–83.
31. Fujinami, A., Ohta, K., Obayashi, H., Fukui, M., Hasegawa, G., & Nakamura, N. (2008). Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clinical Biochemistry, 41(10–11), 812–7.
32. Gaudieri, P. A., Chen, R., Greer, T. F., & Holmes, C. S. (2008). Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care, 31, 1892–1897.
33. Gold, S. M., Dziobek, I., Sweat, V., Tirsi, A., Rogers, K., Bruehl, H., et al. (2007). Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia, 50, 711–719.
34. Hayashi, K., Kurioka, S., Yamaguchi, T., Morita, M., Kanazawa, I., Takase, H., et al. (2011). Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes. Diabetes Research and Clinical Practice, 94, 180–185.
35. Hempel, R., Onopa, R., & Convit, A. (2012). Type 2 diabetes affects hippocampus volume differentially in men and women. Diabetes/Metabolism Research and Reviews, 28, 76–83.
36. Herrero, M. T., Barcia, C., & Navarro, J. M. (2002). Functional anatomy of thalamus and basal ganglia. Child’s Nervous System, 18, 386–404.
37. Hershey, T., Perantie, D. C., Wu, J., Weaver, P. M., Black, K. J., et al. (2010). Hippocampal volumes in youth with type 1 diabetes. Diabetes, 59, 236–241.
38. Higgins, J., Thompson, S., Deeks, J., & Altman, D. (2003). Measuring inconsistency in meta-analysis. BMJ, 327, 557–560.
39. Jongen, C., van der Grond, J., Kappelle, L. J., Biessels, G. J., Viergever, M. A., & Pluim, J. P. (2007). Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia, 50, 1509–1516.
40. Kamiyama, K., Wada, A., Sugihara, M., Kurioka, S., Hayashi, K., Hayashi, T., et al. (2010). Potential hippocampal region atrophy in diabetes mellitus type 2: a voxel-based morphometry VSRAD study. Japanese Journal of Radiology, 28, 266–272.
41. Karege, F., Perret, G., Bondolfi, G., Schwald, M., & Bertschy, G. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research, 109, 143–8.
42. Katon, W., Lyles, C. R., Parker, M. M., Karter, A. J., Huang, E. S., & Whitmer, R. A. (2012). Association of depression with increased risk of dementia in patients with type 2 diabetes. Archives of General Psychiatry, 69, 410–417.
43. Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., et al. (2007). Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. The Journal of Neuroscience, 27, 6174–84.
44. Korczak, D. J., Pereira, S., Koulajian, K., Matejcek, A., & Giacca, A. (2011). Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia, 54(10), 2483–93.
45. Korf, E. S., White, L. R., Scheltens, P., & Launer, L. J. (2006). Brain aging in very old men with type 2 diabetes. Diabetes Care, 29, 2268–2274.
46. Kumar, A., Haroon, E., Darwin, C., Pham, D., Ajilore, O., Rodriguez, G., & Mintz, J. (2008). Gray matter prefrontal changes in type 2 diabetes detected using MRI. Journal of Magnetic Resonance Imaging, 27, 14–19.
47. Laake, J.P., Stahl, D., Amiel, S.A., Petrak, F., Sherwood, R.A., Pickup, J.C., & Ismail, K. (2014). The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the south london diabetes study. Diabetes Care, May 19. pii: DC_132522. (Epub ahead of print).
48. Last, D., Alsop, D. C., Abduljalil, A. M., Marquis, R. P., de Bazelaire, C., Hu, K., et al. (2007). Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care, 30(5), 1193–9.
49. Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., et al. (2009). Reduced O-GlcNAcylation links lower brain glucose metabolism and tau phosphorylation in Alzheimer’s disease. Brain, 132, 1820–1832.
50. Lobnig, B. M., Krömeke, O., Optenhostert-Porst, C., & Wolf, O. T. (2005). Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabetic Medicine, 23, 32–39.
51. Lu, F. P., Lin, K. P., & Kuo, H. K. (2009). Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One, 4(1), e4144.
52. Mangia, S., Tesfaye, N., De Martino, F., Kumar, A. F., Kollasch, P., Moheet, A. A., et al. (2012). Hypoglycemia-induced increases in thalamic cerebral blood flow are blunted in subjects with type 1 diabetes and hypoglycemia unawareness. Journal of Cerebral Blood Flow & Metabolism, 32, 2084–2090.
53. Manor, B., Newton, E., Abduljalil, A., & Novak, V. (2012). The relationship between brain volume and walking outcomes in older adults with and without diabetic peripheral neuropathy. Diabetes Care, 35, 1907–1912.
54. Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008). Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care, 31, 2383–2390.
55. Musen, G., Lyoo, I. K., Sparks, C. R., Weinger, K., Hwang, J., Ryan, C. M., et al. (2006). Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes, 55, 326–333.
56. Musen, G., Jacobson, A. M., Bolo, N. R., Simonson, D. C., Shenton, M. E., McCartney, R. L., et al. (2012). Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes, 62, 2375–2379.
57. Naguib, J. M., Kulinskaya, E., Lomax, C. L., & Garralda, M. E. (2009). Neuro-cognitive performance in children with type 1 diabetes: a meta analysis. Journal of Pediatric Psychology, 34, 271–282.
58. Necula, M., & Kuret, J. (2004). Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. The Journal of Biological Chemistry, 279, 49694–49703.
59. Northam, E. A., Rankins, D., Lin, A., Wellard, R. M., Pell, G. S., Finch, S. J., et al. (2009). Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care, 32, 445–450.
60. Novak, V., Zhao, P., Manor, B., Sejdic, E., Alsop, D., Abduljalil, A., et al. (2011). Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care, 34, 2438–2411.
61. Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A., Hofman, A., Breteler, M. M. (1999). Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology, 53(9), 1937–42.
62. Oxford centre for functional magnetic resonance imaging of the brain. (2003). Oxford thalamic connectivity atlas: www2.fmrib.ox.ac.uk/connect.
63. Perantie, D. C., Wu, J., Koller, J. M., Lim, A., Warren, S. L., Black, K. J., et al. (2007). Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care, 30, 2331–2337.
64. Perantie, D. C., Koller, J. M., Weaver, P. M., Lugar, H. M., Black, K. J., White, N. H., et al. (2011). Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes, 60, 3006–3014.
65. Pickup, J. C., & Crook, M. A. (1998). Is type II diabetes a disease of the innate immune system? Diabetologia, 41, 1241–1248.
66. Sarac, K., Akinci, A., Alkan, A., Aslan, M., Baysal, T., & Ozcan, C. (2007). Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes. Neuroradiology, 47, 562–565.
67. Scott, K. M., Von Korff, M., Angermeyer, M. C., Benjet, C., Bruffaerts, R., de Girolamo, G., et al. (2011). Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions. Archives of General Psychiatry, 68(8), 838–44.
68. Sima, A. A., Zhang, W., Kreipke, C. W., Rafols, J. A., & Hoffman, W. H. (2009). Inflammation in diabetic encephalopathy is prevented by C-peptide. The Review of Diabetic Studies, 6, 37–42.
69. Stamler, J., Vaccaro, O., Neaton, J. D., & Wentworth, D. (1993). Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16(2), 434–44.
70. Stetler, C., & Miller, G. E. (2011). Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosomatic Medicine, 73, 114–26.
71. Teicher, M. H., Andersen, S. L., Polcari, A., Anderson, C. M., Navalta, C. P., & Kim, D. M. (2003). The neurobiological consequences of early stress and childhood maltreatment. Neuroscience and Biobehavioral Reviews, 27(1–2), 33–44.
72. Tesfomariam, B., Brown, M. L., & Cohen, R. A. (1991). Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. The Journal of Clinical Investigation, 87, 1643–1648.
73. Tiehuis, A. M., van der Graaf, Y., Visseren, F. L., Vincken, K. L., Biessels, G. J., Appelman, A. P., et al. (2008). Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke, 39, 1600–1603.
74. Twist, K., Stahl, D., Amiel, S. A., Thomas, S., Winkley, K., & Ismail, K. (2013). Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosomatic Medicine, 75(8), 791–7.
75. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage, 15(1), 273–89.
76. van Elderen, S. G., Brandts, A., van der Grond, J., Westenberg, J. J., Kroft, L. J., van Buchem, M. A., et al. (2011). Cerebral perfusion and aortic stiffness are independent predictors of white matter brain atrophy in type 1 diabetic patients assessed with magnetic resonance imaging. Diabetes Care, 34, 459–463.
77. Videbech, P., & Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry, 161(11), 1957–1966.
78. Viechtbauer, W. (2010). Conducting meta-analyses in R with the metafor package. Journal of Statistical Software, 36(3), 1–48.
79. Watari, K., Elderkin-Thompson, V., Ajilore, O., Haroon, E., Darwin, C., et al. (2008). Neuroanatomical correlates of executive functioning in depressed adults with type 2 diabetes. Journal of Clinical and Experimental Neuropsychology, 30(4), 389–397.
80. Wessels, A. M., Simsek, S., Remijnse, P. L., Veltman, D. J., Biessels, G. J., Barkhof, F., et al. (2006). Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia, 49, 2474–2480.
81. Wessels, A. M., Rombouts, S. A., Remijnse, P. L., Boom, Y., Scheltens, P., Barkhof, F., et al. (2007). Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia, 50, 1763–1769.
82. Williams, S. B., Goldfine, A. B., Timimi, F. K., Ting, H. H., Roddy, M. A., Simonson, D. C., & Creager, M. A. (1998). Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation, 97, 1695–1701.
83. Yau, P. L., Javier, D. C., Ryan, C. M., Tsui, W. H., Ardekani, B. A., Ten, S., et al. (2010). Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia, 58, 2298–2306.